Using a NotI linking clone NR-025 as a probe, we isolated a novel putative member of the RB binding protein family, namely a human retinoblastoma binding protein 2 homologue (RBBP2H1A). The maximal open reading frame encodes a protein of 1681 amino acids. Homology analysis indicated that the predicted product has an overall 56% amino acid identity to RBBP2, which plays an important role in RB tumor suppressor regulation. Many extended regions are 100% identical in amino acids sequences. The degree of nucleotide identity is lower. The structure prediction analysis identified three DNA-binding zinc finger domains and two bipartite nuclear localization signals. Northern expression analysis revealed expression in all tissues; however, the level of expression significantly varied between tissues. The highest level of expression was detected in testis and the lowest in skeletal muscle. The mRNA sizes corresponding to two major products are around 6kb and 7kb. Using fluorescence in situ hybridization, we mapped the gene to chromosomal band 1q32
Introduction
Several years ago, we proposed an approach to combine physical and gene mapping methods to characterize large regions of human chromosomes 1, 2 and NotI linking and jumping clones were proposed as framework markers. We then developed simplified new procedures for jumping and linking library construction and made a number of chromosome 3 specific and total human NotI linking libraries. 3 One thousand NotI linking clones from the chromosome 3 specific grids were partially sequenced and were found to represent 249 unique clones. Among these, we carefully analyzed 150 clones. 4 The results confirmed previous suggestions from us and others that: (i) NotI sites are frequently associated with human genes and (ii) that the sequence data generated can serve as an framework for joining and closing of other types of maps. [4] [5] [6] [7] We therefore decided to sequence all NotI sites in the entire human genome in the search for the new genes and to generate framework markers. The results of a pilot study, consisting of about 10% of the entire clone collection, have been analysed and will be presented elsewhere. Our analysis showed that a surprisingly large number (more than 40%) of NotI clones have identity with ESTs. It can be nevertheless being concluded that data from our NotI project are complementary to data obtained from various EST projects. We have thus confirmed the opinion that NotI sites are located predominantly at the 5' end of genes while the majority of the EST clones have obviously been produced with oligo dT primers resulting in over-representation of the 3' end of genes. 8, 9 Our NotI project on the entire human genome has already resulted in the discovery of many new genes. Here we report on a novel putative member of the RB binding protein family, namely a human retinoblastoma binding protein 2 homologue RBBP2H1A.
Materials and methods
Construction of NotI linking libraries was described previously. 3 Sequencing was done using ABI377 sequencers according to standard procedures. Homology searches were performed using blastx and blastn programs at the NCBI server. 10, 11 Search of protein profiles against the PROSITE-library was done at the ISREC server (http://www.isrec.isb-sib.ch/ software/PFSCAN|form.html).
Eukaryotic promoters prediction by neural network (NNPP) was done at the BCM server (http://dot.imgen .bcm.tmc.edu:9331/seq-search/gene-search.html).
The hybridization with MTN northern filters (Clontech, Palo Alto, CA, USA) was done according to the manufacturer's protocols.
The standard procedure of fluorescence in situ hybridization (FISH) analysis with metaphase chromosomes and DNA fibres was performed as described previously.
12,13

Results and discussion
To check the validity of similarities between NotI-linking clone sequences and genes we selected clone NR-025. We sequenced an area of about 500 bp surrounding this NotI site. The sequence displayed 51% identity over 35 amino acids with retinoblastoma binding protein 2 (RBBP2).
14 No significant similarity was found based on nucleic acids (64.8% identity in 108 bp overlap). After extending the sequenced area to 1.2 kb we found two EST clones with overlapping sequences (AA729218 and AA232348). Using these two cDNAs and a combination of different methods, ie cDNA library screening, RT-PCR and in silico-cloning, we finally obtained the sequence of 7450 bp which includes 779 bp of 5' genomic sequences and 6671 bp of cDNA sequences (Accession No. AJ243706). This combined sequence encodes a predicted protein of 1681 amino acids ( Figure 1 , 2). The protein displays a high level of amino acid identity to RBBP2 (see Figure 2 ). In fact, in many extended regions they are completely identical. This is the reason why we called this gene RBBP2H1A (Rb binding protein 2 homologue 1A). Nevertheless, nucleic acid identity is much less profound, in the best cases reaching 79-84%. Search with the amino acid sequences of the gene using ProfileScan at the ISREC server (see Materials and Methods) revealed many potential domains (Figure 1b) . Among them the most obvious were three Zn-finger domains (446-496 aa, 1313-1361 aa and 1621-1675 aa) and bipartite nuclear localization signals (1239-1256 aa and 1536-1553 aa). There are also many other motifs, like amidation sites, cAMP-and cGMP-dependent protein kinase phosphorylation sites, casein kinase II phosphorylation sites, etc. We suggest that two methionine residues could correspond to the start codon: no. 1 in Figure 2 (758 bp) and no. 61 (938 bp). Located upstream are two predicted promoter sites (555-605 bp and 816-866 bp). Specific experiments must be conducted to determine which of them is the correct starting point but here we suggest that the first methionine is indeed the start. The basis for this is that we have found 5' cDNA clone (AA729218) 15 On the other hand genes can also have multiple promoters. A predicted molecular weight of the longest polypeptide is 185 kDa.
We performed an analysis of the expression with cDNA clone AA232348 as a probe (1080-4510 bp, see AJ243706), using MTN northern filters containing polyA + RNAs from 15 different human tissues (Clontech). Two bands of approximately 6 kb and 7 kb were found ( Figure 3 ). However, testis RNA most probably contains another band, 8.5 kb in size. The gene is expressed in all tested tissues but the level of the expression varies very significantly. The highest level of expression was detected in testis and the lowest in skeletal muscle. Moreover, the ratio between the two main bands also varied between tissues.
We have tested renal cell carcinoma (RCC) biopsies (four cases) and 10 RCC cell lines. No noticeable changes in expression were detected (data not shown).
Using FISH, we assigned the genomic clone NR-025 to chromosomal band 1q32.1 (Figure 4) . To test the integrity of the NR-025 linking clone, we performed the fiber FISH. This experiment revealed the absence of any significant rearrangements and confirmed the integrity of the NR-025 (data not shown).
No significant deletions or rearrangements have been reported in the literature to be associated with this area. However, in the region another RB-binding protein, RBQ-3, was mapped by Saijo et al. 16 After we started to clone this gene, Ueki et al 17 published a paper that described a new method for cloning nucleartargeted proteins. Among other genes and gene fragments, they isolated a cDNA (AB015348) that contains the 3' end of the RBBP2H1A. The homology starts from amino acid 1218 of RBBP2H1A. The AB015348 cDNA clone contains a deletion of five amino acids at the extreme 3' end of our gene (1595-1600 aa). Ueki et al 17 have also shown that their candidate gene fragment is coding for a nuclear-targeted protein, allowing us to speculate that the complete gene isolated in the present study is also localized in the cell nucleus. During the preparation of the manuscript a new entry in the EMBL database was revealed. In March 1999 Vogt et al (AF087481) reported the sequence of a new RBBP2 homologous protein (RBBP2H1) and noted that expression of this gene is differentially regulated during progression of malignant melanomas. The sequence of RBBP2H1 is very similar to the sequence of RBBP2H1A with small deletions/ insertions or changes involving ten amino acids. Two significant differences were revealed, however. Our sequence is missing amino acids 238-273 of RBBP2H1 and at the same time the starting methionine in their sequence is only the third in our sequence (137 aa). Thus, RBBP2H1 is 101 amino acids shorter than RBBP2H1A described in the present study.
In May 1999 Lu et al 18 published the isolation and sequencing of a new gene PLU-1. This gene is identical to our gene starting from 1080 bp; thus our gene is 137 aa longer. Northern expression data are strikingly different for RBBP2H1A and PLU-1. Lu et al 18 reported highly restricted expression of PLU-1 in adult tissues. PLU-1 showed high expression in testis and low levels of expression in placenta, ovary and tonsil. We detected two RNA bands (6 kb and 7 kb) in all 15 tested normal adult tissues (in testis even 3 RNA species were detected, additional 8.5 kb band is also seen). However, the level of expression varied very significantly in these tissues. In skeletal muscles and small intestine expression is hardly detected and in testis it is very strong. It is important to mention that we used as a probe a cDNA clone containing a majority of the RBBP2H1A coding sequences including 5' part absent in the PLU-1 probe (1080-4510 bp). The authors reported elevated expression of PLU-1 in breast cancer. As was mentioned above, we found no elevated expression in RCC biopsies and cell lines.
One explanation of all the results from different groups is that these genes represent alternatively spliced mRNAs of the same gene. Alternatively, these genes may represent closely related members of the same gene family. As the RBBP2H1A and PLU-1 were mapped to the same chromosomal band it is more likely that they represent splice variants of the same gene but further experiments are needed to resolve this question. 
